Revvity, Inc
$16.83B- Market cap
- $14.53B
- Debt
- +$3.22B
- Cash
- −$919.86M
Capital structure 82% equity / 18% debt · EV / Revenue 5.89x · EV / EBITDA 22.11x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $14.53B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: RVTY stock price at premium vs BKR $130.22 current versus $50.42 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BKR's multiple
Implied fair value · at RVTY's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Premium justified
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: RVTY FY 2025 (ended Dec 28, 2025) · BKR FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 82% equity / 18% debt · EV / Revenue 5.89x · EV / EBITDA 22.11x
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 91% equity / 9% debt
BKR carries the larger enterprise value at $69.12B against $16.83B; BKR trades on the lower EV / Revenue multiple (2.49x vs 5.89x); BKR on the lower EV / EBITDA (15.99x vs 22.11x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
REVVITY, INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Baker Hughes Company · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.44x
0.32x
Net debt / EBITDA
Leverage against operating earnings
3.02x
—
Cash and equivalents
Liquid reserves on the balance sheet
$919.86M
—
Total debt
Interest-bearing obligations outstanding
$3.22B
$6.09B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AGILENT TECHNOLOGIES, INC.
RVTY vs A
WATERS CORP /DE/
RVTY vs WAT
BIO-RAD LABORATORIES, INC.
RVTY vs BIO
METTLER TOLEDO INTERNATIONAL INC/
RVTY vs MTD
DANAHER CORP /DE/
RVTY vs DHR
THERMO FISHER SCIENTIFIC INC.
RVTY vs TMO
HALLIBURTON CO
RVTY vs HAL
SCHLUMBERGER LIMITED/NV
RVTY vs SLB
NOV Inc.
RVTY vs NOV
TechnipFMC plc
RVTY vs FTI
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.